NEOPLASM, BREAST
Clinical trials for NEOPLASM, BREAST explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM, BREAST trials appear
Sign up with your email to follow new studies for NEOPLASM, BREAST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets Gene-Mutated breast cancer after first treatment fails
Disease control OngoingThis phase 2 trial tests whether adding alpelisib to continued fulvestrant can help people with advanced, hormone-receptor-positive, HER2-negative breast cancer that has a PIK3CA mutation. Participants have already seen their cancer progress while on fulvestrant. The study aims t…
Matched conditions: NEOPLASM, BREAST
Phase: PHASE2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug shows promise for stubborn cancers
Disease control OngoingThis study tests a new drug called 9-ING-41, given alone or with chemotherapy, in adults with cancers that have not responded to standard treatments. The goal is to see if the drug is safe and can help control the disease. About 350 people with various advanced cancers, including…
Matched conditions: NEOPLASM, BREAST
Phase: PHASE2 • Sponsor: Actuate Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New online tool aims to clear up confusion around cancer screening
Knowledge-focused TerminatedThis study aimed to create a web-based decision aid for people invited to cancer screening in Sweden. The tool would provide clear information about the benefits and harms of screening, helping individuals decide based on knowledge rather than fear. The study was withdrawn before…
Matched conditions: NEOPLASM, BREAST
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC